SELLAS Life Sciences Group, Inc. (SLS)
7.545
+0.26
(+3.50%)
USD |
NASDAQ |
May 19, 15:33
SELLAS Life Sciences Group Research and Development Expense (Quarterly) : 5.129M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Rezolute, Inc. | 11.41M |
| Krystal Biotech, Inc. | 13.81M |
| Spero Therapeutics, Inc. | 2.909M |
| Recursion Pharmaceuticals, Inc. | 75.20M |
| Whitehawk Therapeutics, Inc. | 17.23M |